A5065748121- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
- Animal Virus Infections Studies
- Viral Infections and Immunology Research
- Viral Infections and Outbreaks Research
- Vaccine Coverage and Hesitancy
- SARS-CoV-2 detection and testing
Nference (United States)
2021
Although clinical trials and real-world studies have affirmed the effectiveness safety of FDA-authorized COVID-19 vaccines, reports breakthrough infections persistent emergence new variants highlight need to vigilantly monitor these vaccines. Here we compare two full-length Spike protein-encoding mRNA vaccines from Moderna (mRNA-1273) Pfizer/BioNTech (BNT162b2) in Mayo Clinic Health System over time January July 2021, during which either Alpha or Delta variant was highly prevalent. We...
Continuous assessment of the effectiveness and safety US Food Drug Administration-authorized SARS-CoV-2 vaccines is critical to amplify transparency, build public trust, ultimately improve overall health outcomes.To evaluate Johnson & Ad26.COV2.S vaccine for preventing infection.This comparative research study used large-scale longitudinal curation electronic records from multistate Mayo Clinic Health System (Minnesota, Arizona, Florida, Wisconsin, Iowa) identify vaccinated unvaccinated...
Although clinical trials and real-world studies have affirmed the effectiveness safety of FDA-authorized COVID-19 vaccines, reports breakthrough infections persistent emergence new variants highlight need to vigilantly monitor these vaccines. Here we compare two full-length Spike protein-encoding mRNA vaccines from Moderna (mRNA-1273) Pfizer/BioNTech (BNT162b2) in Mayo Clinic Health System over time January July 2021, during which either Alpha or Delta variant was highly prevalent. We...
Abstract In light of the massive and rapid vaccination campaign against COVID-19, continuous real-world effectiveness safety assessment FDA-authorized vaccines is critical to amplify transparency, build public trust, ultimately improve overall health outcomes. this study, we leveraged large-scale longitudinal curation electronic records (EHRs) from multi-state Mayo Clinic system (MN, AZ, FL, WN, IA). We compared infection rate 2,195 individuals who received a single dose Ad26.COV2.S vaccine...
mRNA coronavirus disease 2019 (COVID-19) vaccines are safe and effective, but increasing reports of breakthrough infections highlight the need to vigilantly monitor compare effectiveness these vaccines.
In light of the massive and rapid vaccination campaign against COVID-19, continuous real-world effectiveness safety assessment FDA-authorized vaccines is critical to amplify transparency, build public trust, ultimately improve overall health outcomes. this study, we leveraged large-scale longitudinal curation electronic records (EHRs) from multi-state Mayo Clinic system (MN, AZ, FL, WN, IA). We compared infection rate 2,195 individuals who received a single dose Ad26.COV2.S vaccine Johnson &...